Pediatr Transplant. 2010 Sep 29. doi: 10.1111/j.1399-3046.2010.01366.x. [Epub ahead of print]
Department of Pediatrics, Pediatric Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran Immunogenetics Laboratory, Department of Immunology, Tehran University of Medical Sciences, Tehran, Iran.
Zeinaloo AA, Zanjani KS., Bagheri MM., Mohyeddin-Bonab M, Monajemzadeh M, Arjmandnia MH. Intracoronary administration of autologous mesenchymal stem cells in a critically ill patient with dilated cardiomyopathy. Pediatr Transplantation 2010. © 2010 John Wiley & Sons A/S. Abstract: Relatively high prevalence of dilated cardiomyopathy in children, unfavorable response to traditional drug therapy, and limitations in heart transplantation call for new therapeutic options. Stem cell therapy can be promising in children suffering from this disease. The presented case documents that intracoronary injection of autologous bone marrow-derived mesenchymal stem cells in a boy with progressive dilated cardiomyopathy is feasible and safe. Furthermore, it may positively influence functional class, quality of life, and echocardiographic indices of cardiac function.
© 2010 John Wiley & Sons A/S.
PMID: 20880092 [PubMed – as supplied by publisher]